dc.contributor.author |
Laufer, Stefan |
|
dc.date.accessioned |
2020-09-16T10:19:05Z |
|
dc.date.available |
2020-09-16T10:19:05Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
1043-6618 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/106889 |
|
dc.language.iso |
en |
en |
dc.publisher |
Academic Press Ltd - Elsevier Science Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.phrs.2020.104859 |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Candidate drugs against SARS-CoV-2 and COVID-19 |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20200715072417_00064 |
|
utue.personen.roh |
McKee, Dwight L. |
|
utue.personen.roh |
Sternberg, Ariane |
|
utue.personen.roh |
Stange, Ulrike |
|
utue.personen.roh |
Laufer, Stefan |
|
utue.personen.roh |
Naujokat, Cord |
|
dcterms.isPartOf.ZSTitelID |
Pharmacological Research |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 104859 |
de_DE |
dcterms.isPartOf.ZS-Volume |
157 |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
|